Research programme: tuftsin based therapeutics - EndocyteAlternative Names: Anti-inflammatory therapeutics - Endocyte; Pentapeptide tuftsin analogue - Endocyte; Tetrameric tuftsin aminopterin conjugate - Endocyte; TKPPR - Endocyte
Latest Information Update: 31 Oct 2014
At a glance
- Originator Endocyte
- Class Drug conjugates; Peptide fragments; Peptides
- Mechanism of Action Immunosuppressants; Macrophage stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Autoimmune disorders; Inflammation